UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Life Science

The skin safari: looking back on a decade of skin microbiome discoveries

Ahead of the Microbiome and Probiotics R&D and Business Collaboration Forum, Dr Monty Lyman takes us on a journey through the last decade of ground-breaking skin microbiome research, and peers ahead into the next.

Read More

Novel biomarkers and the development of a point-of-care test for fatty liver disease

Ahead of The 3rd Global NASH Congress, DrĀ Bevin Gangadharan explains how he helped to discover novel NAFLD biomarkers and their role in the development of a point-of-care test for NAFLD.

Read More

9 Specifications to guide successful Automated sampling in Bioprocessing

Automation and digitisation are becoming increasingly important in the modern environment of bioprocesses 4.0. A new wave of biopharmaceutical manufacturing is already breaking. Driven by the PAT initiativeĀ and the goal of a well-understood and optimally controlled process, the digital transformation of bioprocesses is inevitable.

Read More

Screening for NAFLD in primary care: a preventative wonder or are we barking up the wrong tree?

The burden of chronic liver disease has a substantial health and economic burden within the UK. Chronic liver disease is the fifth most common cause of death in the UK and of those five, it is the only one with numbers that are rising. With this in mind, it would make sense that earlier detection of liver disease in primary care is key to improving outcomes and reducing costs.

Read More

Why is healthcare so vulnerable to cybercrime?

When it comes to cybersecurity, healthcare systems are some of the most difficult to secure, not just because of technological issues. Healthcare providers also need to make difficult decisions about investing in information technologies, security, or the staff and medical facilities which deliver front line healthcare services.

Read More

CE and HPLC applications for rAAV characterisation

Despite recent advances in the gene therapy field, significant challenges lie ahead for the consistent manufacturing and release of these medicines. Analytical methods and automation need to keep pace as more medicines move towards the market and more quality control resources are required. Well-developed methods on robust platforms will be crucial to ensure the quality of these novel medicines for the doctors and patients who need them.

Read More

Improving the selection of candidate CD8+ T cell epitopes for immunotherapy

Alongside the talks at our conferences, the poster presentations are a huge part of the knowledge sharing that takes place. We’re thrilled to be able to take a closer look at this poster from the Research & Technology Series, presented by Wim van Esch and the team at Sanquin.

Read More

Inspirata and Cirdan Announce New Technical Partnership at the Digital Pathology & AI Congress

At the 6th Digital Pathology & AI Congress, Inspirata and Cirdan announced their new technical partnership designed to empower NHS clinical laboratories to accelerate their use of digital pathology.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive